Common Contracts

MASTER DEVELOPMENT AND MANUFACTURING AGREEMENT

Confidential Treatment • June 18th, 2018 • Magenta Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Confidential Treatment
• Filed
  June 18th, 2018
• Company
  Magenta Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Master Development and Manufacturing Agreement (including all appendices hereto, this “Agreement”) is entered into as of February 13, 2018 (the “Effective Date”) by and between Magenta Therapeutics, Inc., a Delaware corporation having offices at 50 Hampshire Street, 8th Floor, Cambridge, MA 02139 (“Magenta”), and Bachem Americas, Inc., a California corporation, having offices at 3132 Kashiwa Street, Torrance, CA 90505 (“Bachem”). Magenta and Bachem may be referred to individually as a “Party” or collectively as the “Parties.”

MASTER DEVELOPMENT AND MANUFACTURING AGREEMENT

Confidential Treatment • May 24th, 2018 • Magenta Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Confidential Treatment
• Filed
  May 24th, 2018
• Company
  Magenta Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Master Development and Manufacturing Agreement (including all appendices hereto, this “Agreement”) is entered into as of February 13, 2018 (the “Effective Date”) by and between Magenta Therapeutics, Inc., a Delaware corporation having offices at 50 Hampshire Street, 8th Floor, Cambridge, MA 02139 (“Magenta”), and Bachem Americas, Inc., a California corporation, having offices at 3132 Kashiwa Street, Torrance, CA 90505 (“Bachem”). Magenta and Bachem may be referred to individually as a “Party” or collectively as the “Parties.”

MASTER DEVELOPMENT AND MANUFACTURING AGREEMENT

Confidential Treatment • March 28th, 2018 • Magenta Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Confidential Treatment
• Filed
  March 28th, 2018
• Company
  Magenta Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Master Development and Manufacturing Agreement (including all appendices hereto, this “Agreement”) is entered into as of February 13, 2018 (the “Effective Date”) by and between Magenta Therapeutics, Inc., a Delaware corporation having offices at 50 Hampshire Street, 8th Floor, Cambridge, MA 02139 (“Magenta”), and Bachem Americas, Inc., a California corporation, having offices at 3132 Kashiwa Street, Torrance, CA 90505 (“Bachem”). Magenta and Bachem may be referred to individually as a “Party” or collectively as the “Parties.”